Clinical trials
Phase 2 Tachycardia, Ventricular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2023 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardurion Pharmaceuticals, Inc. | 2 |
| Milestone Pharmaceuticals Inc. | 2 |
| Aalborg University Hospital | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Cedars-Sinai Medical Center | 1 |
| David Haines, MD | 1 |
| Gilead Sciences | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tachycardia, Ventricular | 13 |
| Arrhythmias, Cardiac | 5 |
| Ventricular Fibrillation | 5 |
| Death, Sudden, Cardiac | 2 |
| Heart Arrest | 2 |
| Heart Diseases | 2 |
| Heart Defects, Congenital | 1 |
| Kidney Failure, Chronic | 1 |
| Polymorphic Catecholaminergic Ventricular Tachycardia | 1 |
| Radiation Injuries | 1 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.